BNP Paribas Financial Markets
RLYB icon

BNP Paribas Financial Markets’s Rallybio RLYB Stock Holding History

BNP Paribas Financial Markets’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92K Hold
120
– – ﹤0.01% 5546
2026
Q1 		$1.08K Sell
120
-3
-2% -$21 ﹤0.01% 5470
2025
Q4 		$672 Hold
123
– – ﹤0.01% 5446
2025
Q3 		$489 Hold
123
– – ﹤0.01% 5312
2025
Q2 		$332 Hold
123
– – ﹤0.01% 5255
2025
Q1 		$643 Sell
123
-15
-11% -$95 ﹤0.01% 5115
2024
Q4 		$1.06K Buy
+138
New +$1.16K ﹤0.01% 5075

Other funds holding RLYB

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Financial Markets's RLYB Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Rallybio (RLYB) position steady in Q2 2026 at 120 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #5546.

BNP Paribas Financial Markets first reported a position in RLYB in Q4 2024 and has held it in 7 quarters since. 24 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • BNP Paribas Financial Markets held 120 shares of Rallybio worth $1.92K as of Q2 2026.
  • BNP Paribas Financial Markets left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5546 holding.
  • BNP Paribas Financial Markets first reported a position in Rallybio in Q4 2024 and has held it in 7 quarters since.
  • 24 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.